Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Immunosuppressed Adult Zebrafish Model of Mucormycosis

A. M. Tatara, S. Wurster, C. R. Lockworth, N. D. Albert, T. J. Walsh, A. G. Mikos, G. T. Eisenhoffer, D. P. Kontoyiannis
A. M. Tatara
aMedical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA
eDepartment of Bioengineering, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Wurster
bDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Wurster
C. R. Lockworth
cDepartment of Veterinary Medicine and Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. D. Albert
bDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. J. Walsh
dTransplantation-Oncology Infectious Diseases Program, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. G. Mikos
eDepartment of Bioengineering, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. T. Eisenhoffer
fDepartment of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. P. Kontoyiannis
bDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00698-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Mucormycosis is a life-threatening, rapidly progressing infection associated with high mortality. Current challenges include a limited arsenal of available antifungals and an incomplete understanding of disease pathogenesis (1). Therefore, new models which can act as platforms for studying disease mechanisms and therapeutic actions are of high priority to the field.

The adult zebrafish, an emerging model in the study of infectious diseases (2), offers several advantages over other vertebrate model organisms, such as high fecundity, mature immune responses, reduced housing costs, and an array of tools for genetic manipulation. While larval zebrafish models of mucormycosis have been explored (3), zebrafish larvae lack a mature adaptive immune system (4). As hosts most susceptible to mucormycosis have defects in both innate and adaptive immunity (1), we sought to develop an adult zebrafish model of mucormycosis with and without immunosuppression.

Female adult zebrafish 6 months or older (AB ZIRC catalog no. ZL1; ZFIN ID ZDB-GENO-960809-7, available from the University of Oregon [https://zfin.org/ZDB-GENO-960809-7]) and weighing 235 to 250 mg were divided into three groups: immunosuppressed via cyclophosphamide and noninfected (CP), nonimmunosuppressed and infected by Rhizopus oryzae (RO), and immunosuppressed and infected (CP+RO). One day prior to inoculation, animals received 10-μl subcutaneous injections adjacent to the pelvic fin of either 300 mg/kg cyclophosphamide (Sigma-Aldrich, St. Louis, MO) for CP and CP+RO animals (5) or saline for RO animals. RO and CP+RO animals were given intramuscular inoculations of 10 μl of 5 × 108 spores/ml Rhizopus oryzae 969 immediately caudal to the dorsal fin. All injections took place under anesthesia using 168 mg/ml tricaine methanesulfonate (Tricaine-S; Syndel USA, Fernadale, WA) as described previously (6). Following inoculation, the animals were monitored twice daily for 7 days under standard conditions prior to euthanasia. Experiments were performed in duplicate with 5 animals per group for a total of 10 animals per group. After death, the animals were subjected to histological analysis with Grocott-Gomori's methenamine silver stain. Kaplan-Meier analysis was performed to determine differences in survival rates with the log-rank test using JMP Pro software (version 11.0; SAS Institute, Cary, NC) (α = 0.05).

CP animals experienced 20% mortality over the course of 7 days (Fig. 1A). Both RO- and CP+RO-infected groups had significantly increased mortality compared to CP animals (70% versus 20%, P = 0.034, and 80% versus 20%, P = 0.012, respectively). There were no significant survival differences between the RO- and CP+RO-infected groups (80% versus 70%, P = 0.6038). The median survival times were >7, 4, and 4 days for the CP, RO, and CP+RO groups, respectively. Histological staining demonstrated extensive mycelium formation in infected animals but not in noninoculated animals (Fig. 1B to D). Hyphae were visible as early as day 2 in the RO+CP group and by day 4 in the RO group.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Zebrafish survival and representative histological images. (A) Survival curve of immunosuppressed (CP), infected (RO), and immunosuppressed and infected (CP+RO) animals. (B to D) Representative images from Grocott-Gomori's methenamine silver stain of tissue from CP animals at day 7 (B), RO animals at day 4 (C), and RO+CP animals at day 4 (D). Black scale bars, 200 μm; red scale bars, 50 μm.

This preliminary work suggests that adult zebrafish experience mortality when infected via intramuscular injection of R. oryzae. Although immunosuppressed animals had 10% greater mortality and hyphal formation was observed earlier in these animals than in nonimmunosuppressed animals, there were no statistically significant differences in overall 7-day survival. This is consistent with the well-known ability of Mucorales, in contrast to other opportunistic fungi, to cause severe or even lethal disease in immunocompetent hosts (1).

ACKNOWLEDGMENTS

This work was supported by the John S. Dunn Foundation and NIH-NCI Cancer Center CORE Support grant no. 16672. A.M.T. thanks the Baylor College of Medicine Medical Scientist Training Program (NIH T32 GM007330) and the Barrow Scholars Program. D.P.K. acknowledges the Texas 4000 Distinguished Professorship for Cancer Research. G.T.E. was supported by the Cancer Prevention Research Institute of Texas (RR14007).

We declare no conflicts of interest.

  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Farmakiotis D,
    2. Kontoyiannis DP
    . 2016. Mucormycoses. Infect Dis Clin North Am 30:143–163. doi:10.1016/j.idc.2015.10.011.
    OpenUrlCrossRef
  2. 2.↵
    1. Sullivan C,
    2. Kim CH
    . 2008. Zebrafish as a model for infectious disease and immune function. Fish Shellfish Immunol 25:341–350. doi:10.1016/j.fsi.2008.05.005.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Voelz K,
    2. Gratacap RL,
    3. Wheeler RT
    . 2015. A zebrafish larval model reveals early tissue-specific innate immune responses to Mucor circinelloides. Dis Model Mech 8:1375–1388. doi:10.1242/dmm.019992.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Lam SH,
    2. Chua HL,
    3. Gong Z,
    4. Lam TJ,
    5. Sin YM
    . 2004. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol 28:9–28. doi:10.1016/S0145-305X(03)00103-4.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Burgos JS,
    2. Ripoll-Gomez J,
    3. Alfaro JM,
    4. Sastre I,
    5. Valdivieso F
    . 2008. Zebrafish as a new model for herpes simplex virus type 1 infection. Zebrafish 5:323–333. doi:10.1089/zeb.2008.0552.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Phelps HA,
    2. Runft DL,
    3. Neely MN
    . 2009. Adult zebrafish model of streptococcal infection. Curr Protoc Microbiol 9:Unit 9D.1. doi:10.1002/9780471729259.mc09d01s13.
    OpenUrlCrossRef
PreviousNext
Back to top
Download PDF
Citation Tools
Immunosuppressed Adult Zebrafish Model of Mucormycosis
A. M. Tatara, S. Wurster, C. R. Lockworth, N. D. Albert, T. J. Walsh, A. G. Mikos, G. T. Eisenhoffer, D. P. Kontoyiannis
Antimicrobial Agents and Chemotherapy Oct 2018, 62 (11) e00698-18; DOI: 10.1128/AAC.00698-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Immunosuppressed Adult Zebrafish Model of Mucormycosis
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunosuppressed Adult Zebrafish Model of Mucormycosis
A. M. Tatara, S. Wurster, C. R. Lockworth, N. D. Albert, T. J. Walsh, A. G. Mikos, G. T. Eisenhoffer, D. P. Kontoyiannis
Antimicrobial Agents and Chemotherapy Oct 2018, 62 (11) e00698-18; DOI: 10.1128/AAC.00698-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Rhizopus
in vivo
mucormycosis
mycology
zebrafish

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596